We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novartis now faces competition to its top-seller Gleevec, a treatment for chronic myeloid leukemia, as Sun Pharma launched its copycat version in the U.S. Monday.